BamSEC and AlphaSense Join Forces
Learn More

Phathom Pharmaceuticals Inc. – Indentures

NASDAQ: PHAT    
Share price (3/30/26): $10.53    
Market cap (3/30/26): $830 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.8
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 12 pages Form of Pre-Funded Warrant to Purchase Common Stock Phathom Pharmaceuticals, Inc
12/34/56
EX-4.7
from S-3ASR 52 pages Phathom Pharmaceuticals, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.8
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 12 pages Form of Pre-Funded Warrant to Purchase Common Stock Phathom Pharmaceuticals, Inc
12/34/56
EX-4.8
from 10-K/A 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.8
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.9
from S-3 52 pages Phathom Pharmaceuticals, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4
from 10-Q 17 pages Form of Warrant Agreement to Purchase Shares of the Common Stock of Phathom Pharmaceuticals, Inc. Dated as of [•], 202[•]
12/34/56
EX-4
from 10-Q 6 pages First Amendment to Warrant
12/34/56
EX-4
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.7
from S-3 51 pages Phathom Pharmaceuticals, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.6
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-1/A 93 pages Phathom Pharmaceuticals, Inc. Note Purchase Agreement May 7, 2019
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.5
from S-1 82 pages Phathom Pharmaceuticals, Inc. Note Purchase Agreement May 7, 2019
12/34/56
EX-4.4
from S-1 14 pages Warrant to Purchase Stock
12/34/56
EX-4.3
from S-1 14 pages Warrant to Purchase Stock
12/34/56